Leinco Technologies

For scientists in the life sciences, biopharmaceutical and diagnostics segments utilizing antibodies, biologically active proteins, assays and buffers, Leinco Technologies, provides access to over 4,000 products (cited in over 3,000 publications), assay development and CDMO services. Our proprietary techniques result in the highest purity antibodies (monoclonal, recombinant and polyclonal) and proteins enabling scientists globally to generate reproducible science and faster time to scientific results across a broad range of cell, tissue and in vivo applications (e.g. spatial biology, flow cytometry, pre-clinical in vivo and in vitro studies). For our many partners, the Leinco scientists with over 30 years’ experience take a consultative approach and are committed to delivering the highest quality services (e.g. antibody scale-up and purification, optimized conjugation to reporter molecules) that save time and ensure our customers are successful in their programs.

The products from Leinco include:

·        in vivo Functional Grade Antibodies

·        SARS-CoV-2 (COVID-19)

·        Primary Monoclonal Antibodies

·        Polyclonal Antibodies

·        Human Biosimilar Antibodies

·        Recombinant Proteins, Growth Factors & Cytokines

·        Isotype Control Antibodies

·        Secondary Antibody Products

·        PhenoCycler-Fusion (CODEX)® Barcoded Antibodies

·        PhenoCycler-Fusion (CODEX)® Validated Antibodies